Foundry Partners’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.04M Sell
21,955
-24,015
-52% -$2.33M 0.11% 200
2024
Q4
$4.94M Sell
45,970
-70
-0.2% -$8.52K 0.25% 135
2024
Q3
$5.79M Sell
46,040
-7,475
-14% -$940K 0.29% 109
2024
Q2
$5.8M Sell
53,515
-680
-1% -$66.3K 0.31% 101
2024
Q1
$5.12M Sell
54,195
-2,100
-4% -$199K 0.27% 126
2023
Q4
$5.2M Buy
56,295
+17,345
+45% +$1.33M 0.31% 113
2023
Q3
$2.49M Buy
+38,950
New +$2.5M 0.16% 183

Other funds holding NHC

Foundry Partners's NHC Position: Q1 2025 in Review

Foundry Partners reduced its National Healthcare (NHC) stake by 52% in Q1 2025, selling an estimated $2.33M and leaving 21,955 shares worth $2.04M. The position accounts for 0.11% of the portfolio, ranked #200.

Foundry Partners first reported a position in NHC in Q3 2023 and has held it in 7 quarters since. The position peaked at $5.8M in Q2 2024. 179 funds tracked by Wall St. Rank hold NHC as of Q1 2025.

  • Foundry Partners held 21,955 shares of National Healthcare worth $2.04M as of Q1 2025.
  • Foundry Partners sold 24,015 National Healthcare shares in Q1 2025, an estimated $2.33M.
  • National Healthcare made up 0.11% of Foundry Partners's portfolio in Q1 2025, its #200 holding.
  • Foundry Partners first reported a position in National Healthcare in Q3 2023 and has held it in 7 quarters since.
  • Foundry Partners's National Healthcare position peaked at $5.8M in Q2 2024.
  • 179 funds tracked by Wall St. Rank held National Healthcare as of Q1 2025.

Based on Foundry Partners's 13F filing for Q1 2025, filed 5 May 2025.